316 related articles for article (PubMed ID: 33676233)
21. An Overview of the Intrinsic Role of Citrullination in Autoimmune Disorders.
Alghamdi M; Alasmari D; Assiri A; Mattar E; Aljaddawi AA; Alattas SG; Redwan EM
J Immunol Res; 2019; 2019():7592851. PubMed ID: 31886309
[TBL] [Abstract][Full Text] [Related]
22. Role of protein deimination in cardiovascular diseases: potential new avenues for diagnostic and prognostic biomarkers.
Mao L; Mostafa R; Ibili E; Fert-Bober J
Expert Rev Proteomics; 2021 Dec; 18(12):1059-1071. PubMed ID: 34929115
[TBL] [Abstract][Full Text] [Related]
23. Citrullination and the protein code: crosstalk between post-translational modifications in cancer.
Harada K; Carr SM; Shrestha A; La Thangue NB
Philos Trans R Soc Lond B Biol Sci; 2023 Nov; 378(1890):20220243. PubMed ID: 37778382
[TBL] [Abstract][Full Text] [Related]
24. Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis.
Wang S; Wang Y
Biochim Biophys Acta; 2013 Oct; 1829(10):1126-35. PubMed ID: 23860259
[TBL] [Abstract][Full Text] [Related]
25. Halogen Bonding Increases the Potency and Isozyme Selectivity of Protein Arginine Deiminase 1 Inhibitors.
Mondal S; Gong X; Zhang X; Salinger AJ; Zheng L; Sen S; Weerapana E; Zhang X; Thompson PR
Angew Chem Int Ed Engl; 2019 Sep; 58(36):12476-12480. PubMed ID: 31276611
[TBL] [Abstract][Full Text] [Related]
26. Identification and Characterization of the Lactating Mouse Mammary Gland Citrullinome.
Li G; Young CH; Snow B; Christensen AO; Demoruelle MK; Nemmara VV; Thompson PR; Rothfuss HM; Cherrington BD
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290104
[TBL] [Abstract][Full Text] [Related]
27. Deimination and Peptidylarginine Deiminases in Skin Physiology and Diseases.
Méchin MC; Takahara H; Simon M
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31952341
[TBL] [Abstract][Full Text] [Related]
28. Discovery of Novel Potential Reversible Peptidyl Arginine Deiminase Inhibitor.
Aliko A; Kamińska M; Falkowski K; Bielecka E; Benedyk-Machaczka M; Malicki S; Kozieł J; Wong A; Bryzek D; Kantyka T; Mydel P
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052493
[TBL] [Abstract][Full Text] [Related]
29. A Pilot Study on Peptidylarginine Deiminases and Protein Deimination in Animal Cancers across Vertebrate Species.
Inal JM; Hristova M; Lange S
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955829
[TBL] [Abstract][Full Text] [Related]
30. Evolution of a mass spectrometry-grade protease with PTM-directed specificity.
Tran DT; Cavett VJ; Dang VQ; Torres HL; Paegel BM
Proc Natl Acad Sci U S A; 2016 Dec; 113(51):14686-14691. PubMed ID: 27940920
[TBL] [Abstract][Full Text] [Related]
31. An interplay of structure and intrinsic disorder in the functionality of peptidylarginine deiminases, a family of key autoimmunity-related enzymes.
Alghamdi M; Al Ghamdi KA; Khan RH; Uversky VN; Redwan EM
Cell Mol Life Sci; 2019 Dec; 76(23):4635-4662. PubMed ID: 31342121
[TBL] [Abstract][Full Text] [Related]
32. Citrullination regulates pluripotency and histone H1 binding to chromatin.
Christophorou MA; Castelo-Branco G; Halley-Stott RP; Oliveira CS; Loos R; Radzisheuskaya A; Mowen KA; Bertone P; Silva JC; Zernicka-Goetz M; Nielsen ML; Gurdon JB; Kouzarides T
Nature; 2014 Mar; 507(7490):104-8. PubMed ID: 24463520
[TBL] [Abstract][Full Text] [Related]
33. Methods for the detection of peptidylarginine deiminase (PAD) activity and protein citrullination.
Hensen SM; Pruijn GJ
Mol Cell Proteomics; 2014 Feb; 13(2):388-96. PubMed ID: 24298040
[TBL] [Abstract][Full Text] [Related]
34. Citrullination of matrisomal proteins in health and diseases.
Saifi MA; Ho IC
Philos Trans R Soc Lond B Biol Sci; 2023 Nov; 378(1890):20220244. PubMed ID: 37778384
[TBL] [Abstract][Full Text] [Related]
35. Development of a highly sensitive fluorescence probe for peptidyl arginine deiminase (PAD) activity.
Kunieda K; Kawaguchi M; Ieda N; Nakagawa H
Bioorg Med Chem Lett; 2019 Apr; 29(7):923-928. PubMed ID: 30773431
[TBL] [Abstract][Full Text] [Related]
36. Histone citrullination: a new target for tumors.
Zhu D; Zhang Y; Wang S
Mol Cancer; 2021 Jun; 20(1):90. PubMed ID: 34116679
[TBL] [Abstract][Full Text] [Related]
37. The protein arginine deiminases: Structure, function, inhibition, and disease.
Bicker KL; Thompson PR
Biopolymers; 2013 Feb; 99(2):155-63. PubMed ID: 23175390
[TBL] [Abstract][Full Text] [Related]
38. Current knowledge into the role of the peptidylarginine deiminase (PAD) enzyme family in cardiovascular disease.
Al-U'datt DGF; Allen BG; Hiram R; Alrabadi N
Eur J Pharmacol; 2021 Jan; 891():173765. PubMed ID: 33249073
[TBL] [Abstract][Full Text] [Related]
39. Citrullination of inhibitor of growth 4 (ING4) by peptidylarginine deminase 4 (PAD4) disrupts the interaction between ING4 and p53.
Guo Q; Fast W
J Biol Chem; 2011 May; 286(19):17069-78. PubMed ID: 21454715
[TBL] [Abstract][Full Text] [Related]
40. Post-translational protein deimination signatures in sea lamprey (Petromyzon marinus) plasma and plasma-extracellular vesicles.
Rast JP; D'Alessio S; Kraev I; Lange S
Dev Comp Immunol; 2021 Dec; 125():104225. PubMed ID: 34358577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
